Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Aytu BioPharma, Inc. - Common Stock (NQ:AYTU)

2.347 -0.013 (-0.57%)
Streaming Delayed Price Updated: 11:41 AM EDT, Oct 13, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Aytu BioPharma, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Aytu BioPharma to Present at Upcoming October 2025 Conferences
Via ACCESS Newswire
11 Company Presentations Today at The MicroCap Rodeo Conference
Via ACCESS Newswire
Aytu BioPharma to Present at Upcoming September 2025 Conferences
Via ACCESS Newswire
Top movers in Wednesday's session
Let's have a look at what is happening on the US markets one hour before the close of the markets on Wednesday. Below you can find the top gainers and losers in today's session. 
Via Chartmill
Earnings Outlook For Aytu BioPharma
 
Via Benzinga
Aytu BioPharma Announces At the Market Pricing of $14.4 Million Upsized Public Offering of Common Stock
Via ACCESS Newswire
12 Health Care Stocks Moving In Wednesday's Intraday Session
 
Via Benzinga
Keep an eye on the top gainers and losers in Wednesday's session.
Stay up-to-date with the latest market trends in the middle of the day on Wednesday. Explore the top gainers and losers during today's session in our detailed report. 
Via Chartmill
Gapping stocks in Wednesday's session
The market is buzzing with gapping stocks on Wednesday. Let's uncover which stocks are experiencing notable gaps during today's session. 
Via Chartmill
Get insights into the top gainers and losers of Wednesday's pre-market session.
Before the US market kicks off on Wednesday, let's examine the pre-market session and unveil the notable performers among the top gainers and losers. 
Via Chartmill
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
 
Via Benzinga
What's going on in today's after hours session
The US market regular session of Tuesday is over, let's have a look at the top gainers and losers in the after hours session today. 
Via Chartmill
Aytu BioPharma Inc (NASDAQ:AYTU) Shares Fall on Q4 Revenue and EPS Miss
Aytu BioPharma shares fell after Q4 2025 results missed revenue and EPS estimates. The company remains focused on the upcoming launch of its depression drug, EXXUA, as a key growth catalyst. 
Via Chartmill
Aytu BioPharma Reports Fiscal 2025 Full Year and Fourth Quarter Operational and Financial Results and Outlines Commercial Launch Plans for EXXUA(TM)
Via ACCESS Newswire
Aytu BioPharma's Q4 2025 Earnings: Anticipation Mounts Ahead of Key EXXUA Launch
NEW YORK, NY – September 23, 2025 – As the trading day concludes, all eyes in the biopharmaceutical sector are turning to Aytu BioPharma (NASDAQ: AYTU), which is poised to release its fiscal... 
Via MarketMinute
Topics Earnings
Dow Futures Gain Ahead Of Jerome Powell’s Speech: BA, HOLO, BETR, CLSK Among Stocks To Watch
Via Stocktwits
Topics Economy Stocks
Earnings Scheduled For September 23, 2025
 
Via Benzinga
Aytu BioPharma to Report Fiscal 2025 Full Year and Fourth Quarter Operational and Financial Results on September 23, 2025
Via ACCESS Newswire
12 Health Care Stocks Moving In Monday's After-Market Session
 
Via Benzinga
This Starbucks Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
 
Via Benzinga
Aytu BioPharma Appoints Dr. Gerwin Westfield as Senior Vice President of Scientific Affairs to Support Commercialization of EXXUA(TM)
Via ACCESS Newswire
Aytu BioPharma Expands and Extends Lending Agreement with Eclipse Following Agreement to Commercialize First-in-Class Antidepressant EXXUA(TM)
Via ACCESS Newswire
Aytu BioPharma Announces Closing of Upsized At the Market Public Offering of Common Stock with Full Exercise of Overallotment and Conference Call to Discuss First-in-Class Antidepressant EXXUA(TM) Opportunity and Commercialization Plan
Via ACCESS Newswire
Which stocks are moving on Friday?
Let's have a look at what is happening on the US markets one hour before the close of the markets on Friday. Below you can find the top gainers and losers in today's session. 
Via Chartmill
Aytu BioPharma Announces Exclusive Agreement with Fabre-Kramer Pharmaceuticals to Commercialize First-in-Class Antidepressant EXXUA(TM) (gepirone) Extended-Release Tablets in the United States
Via ACCESS Newswire
12 Health Care Stocks Moving In Friday's Intraday Session
 
Via Benzinga
These stocks have an unusual volume in today's session
On Friday, there are stocks with unusual volume. Let's take a look. 
Via Chartmill
Top movers in Friday's pre-market session
As we await the opening of the US market on Friday, let's delve into the pre-market session and discover the top gainers and losers shaping the early market sentiment. 
Via Chartmill
12 Health Care Stocks Moving In Friday's Pre-Market Session
 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.